Additional New NXP002 Patent Filing

Cambridge, UK - 28th September 2018

Nuformix, the pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs is pleased to announce a new patent filing in connection with its NXP002 fibrosis programme.

Download News

Back to all News